Study of a new drug to reverse muscle relaxants after surgery
Treatments studied
This study tests a new drug called amogammadex sodium to see if it can quickly reverse the effects of muscle relaxants used during surgery. It may help patients wake up and breathe normally sooner after anesthesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You are scheduled for a surgery that will last about 2 hours under general anesthesia with a breathing tube.
- You will receive a muscle relaxant called vecuronium or rocuronium during your surgery.
- You have a body mass index (BMI) between 18 and 32, and weigh at least 50 kg (men) or 45 kg (women).
- You are generally healthy (classified as ASA 1 or 2 by your anesthesiologist).
- You agree to use effective birth control (or abstain from sex) during the study and for 3 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called sugammadex, which is used to reverse the effects of a muscle relaxant given during anesthesia. It is for adults having general or brain surgery, and aims to help you wake up and breathe more quickly after surgery.
This trial tests a way to reverse the effects of a muscle relaxant used during surgery, aiming to help you recover breathing and muscle control faster after anesthesia.
This study tests a domestic version of sugammadex sodium (a drug that reverses muscle relaxants) after lung surgery. It aims to see how well it works to help you wake up and recover from anesthesia.
This trial tests two different medicines used to reverse muscle relaxation after lung surgery. It looks at which one helps you breathe better in the first hours after your procedure.
This study tests a new medicine (HRS-9190) that helps relax muscles during surgery. It is for people having a planned surgery that lasts 1.5 to 4 hours under general anesthesia with a breathing tube. The goal is to see if the medicine works well and is safe.
This study compares a new muscle relaxant medication with a standard one to see how well they work for placing a breathing tube and maintaining muscle relaxation during surgery. It aims to find a safer or more effective option for patients undergoing general anesthesia.
Hear when a new Reversing Vecuronium-Induced Neuromuscular Blockade in Patients Undergoing General Anesthesia Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.